Compare Stocks: TOI, CDNA, WGS, and TDOC

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CDNA CareDx	$43.71 +14.7%	$28.59	$11.26 ▼ $45.00	$2.26B	2.43	1.07 million shs	2.78 million shs
TDOC Teladoc Health	$6.71 +2.0%	$8.21	$4.40 ▼ $9.89	$1.21B	2.1	5.18 million shs	8.56 million shs
TOI Oncology Institute	$4.86 -4.1%	$5.18	$2.32 ▼ $6.67	$480.36M	0.36	1.89 million shs	1.00 million shs
WGS GeneDx	$65.11 -5.6%	$60.67	$32.21 ▼ $170.87	$1.93B	1.9	637,375 shs	885,649 shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CDNA CareDx	0.00%	+17.69%	+49.74%	+103.30%	+239.89%
TDOC Teladoc Health	0.00%	-23.05%	-26.96%	+3.82%	-9.42%
TOI Oncology Institute	0.00%	-2.41%	-7.95%	+20.00%	+31.71%
WGS GeneDx	0.00%	+10.17%	-3.56%	-0.41%	-37.10%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CDNA CareDx	$43.71 +14.7%	$28.59	$11.26 ▼ $45.00	$2.26B	2.43	1.07 million shs	2.78 million shs
TDOC Teladoc Health	$6.71 +2.0%	$8.21	$4.40 ▼ $9.89	$1.21B	2.1	5.18 million shs	8.56 million shs
TOI Oncology Institute	$4.86 -4.1%	$5.18	$2.32 ▼ $6.67	$480.36M	0.36	1.89 million shs	1.00 million shs
WGS GeneDx	$65.11 -5.6%	$60.67	$32.21 ▼ $170.87	$1.93B	1.9	637,375 shs	885,649 shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CDNA CareDx	0.00%	+17.69%	+49.74%	+103.30%	+239.89%
TDOC Teladoc Health	0.00%	-23.05%	-26.96%	+3.82%	-9.42%
TOI Oncology Institute	0.00%	-2.41%	-7.95%	+20.00%	+31.71%
WGS GeneDx	0.00%	+10.17%	-3.56%	-0.41%	-37.10%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CDNA CareDx	2.00	Hold	$36.75	-15.92% Downside
TDOC Teladoc Health	2.25	Hold	$7.50	11.74% Upside
TOI Oncology Institute	2.60	Moderate Buy	$8.50	74.90% Upside
WGS GeneDx	2.67	Moderate Buy	$87.43	34.28% Upside

Current Analyst Ratings Breakdown

Latest TOI, CDNA, WGS, and TDOC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/31/2026	CDNA CareDx	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral	$46.00
7/30/2026	CDNA CareDx	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D) ➝ Sell (D+)
7/30/2026	TDOC Teladoc Health	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$11.00 ➝ $10.00
7/28/2026	WGS GeneDx	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
7/21/2026	TDOC Teladoc Health	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$10.00 ➝ $11.00
7/17/2026	TOI Oncology Institute	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/16/2026	CDNA CareDx	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold	$35.00
7/16/2026	CDNA CareDx	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
7/16/2026	CDNA CareDx	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$28.00 ➝ $45.00
7/15/2026	CDNA CareDx	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D)
7/15/2026	WGS GeneDx	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy

(Data available from 8/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CDNA CareDx	$379.80M	5.95	$0.01 per share	6,710.78	$5.89 per share	7.42
TDOC Teladoc Health	$2.53B	0.48	$1.80 per share	3.73	$7.81 per share	0.86
TOI Oncology Institute	$502.73M	0.96	N/A	N/A	($0.16) per share	-30.38
WGS GeneDx	$427.54M	4.52	$2.29 per share	28.41	$10.54 per share	6.18

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CDNA CareDx	-$21.35M	-$0.16	21.12	145.70	N/A	24.23%	3.14%	2.32%	N/A
TDOC Teladoc Health	-$200.32M	-$0.99	N/A	N/A	N/A	-7.13%	-12.02%	-5.79%	N/A
TOI Oncology Institute	-$60.61M	-$0.37	N/A	N/A	N/A	-7.42%	N/A	-24.68%	8/6/2026 (Estimated)
WGS GeneDx	-$21.02M	-$2.68	N/A	74.84	N/A	-17.58%	9.15%	5.21%	8/3/2026 (Confirmed)

Latest TOI, CDNA, WGS, and TDOC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	TOI Oncology Institute	-$0.07	N/A	N/A	N/A	$155.28 million	N/A
8/3/2026	Q2 2026	WGS GeneDx	-$0.1879	N/A	N/A	N/A	$111.01 million	N/A
7/30/2026	Q2 2026	CDNA CareDx	$0.2321	$0.37	+$0.1379	$2.07	$113.83 million	$131.95 million
7/29/2026	Q2 2026	TDOC Teladoc Health	-$0.2498	-$0.21	+$0.0398	-$0.21	$615.44 million	$606.93 million
5/7/2026	Q1 2026	TOI Oncology Institute	-$0.07	-$0.02	+$0.05	-$0.02	$142.10 million	$147.44 million
5/4/2026	Q1 2026	WGS GeneDx	-$0.06	-$0.28	-$0.22	-$2.16	$112.46 million	$102.25 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CDNA CareDx	N/A	N/A	N/A	N/A	N/A
TDOC Teladoc Health	N/A	N/A	N/A	N/A	N/A
TOI Oncology Institute	N/A	N/A	N/A	N/A	N/A
WGS GeneDx	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CDNA CareDx	N/A	3.40	3.07
TDOC Teladoc Health	0.75	2.80	2.72
TOI Oncology Institute	N/A	1.47	1.17
WGS GeneDx	0.38	3.09	2.95

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CDNA CareDx	N/A
TDOC Teladoc Health	76.82%
TOI Oncology Institute	36.86%
WGS GeneDx	61.72%

Insider Ownership

Company	Insider Ownership
CDNA CareDx	2.40%
TDOC Teladoc Health	0.70%
TOI Oncology Institute	4.40%
WGS GeneDx	25.17%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CDNA CareDx	740	51.66 million	50.42 million	Optionable
TDOC Teladoc Health	5,600	180.51 million	179.25 million	Optionable
TOI Oncology Institute	660	98.84 million	94.49 million	Not Optionable
WGS GeneDx	1,300	29.69 million	22.22 million	Optionable

TOI, CDNA, WGS, and TDOC Headlines

Recent News About These Companies

GeneDx (WGS) to Release Quarterly Earnings on Monday

1 hour ago | americanbankingnews.com

WGS Deadline: WGS Investors with Losses in Excess of $100K Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit

August 1 at 12:00 AM | prnewswire.com

WGS DEADLINE MONDAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 3 Deadline in Securities Class Action - WGS

August 1 at 11:27 AM | globenewswire.com

WGS CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

August 1 at 6:15 AM | newsfilecorp.comN

GeneDx Holdings Corp. 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against GeneDx ...

July 31 at 10:41 PM | tmcnet.com

GeneDx Holdings Corp (WGS) Shares Fall 5.5% -- What GF Score of 64 Tells Investors

July 31 at 9:00 PM | gurufocus.com

GeneDx Holdings Corp. 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against GeneDx Holdings Corp. - WGS

July 31 at 6:17 PM | businesswire.com

HAGENS BERMAN, SOBOL SHAPIRO LLP ALERT: GeneDx Holdings Corp. (NASDAQ: WGS) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 3, 2026 Lead Plaintiff Deadline

July 31 at 2:47 PM | prnewswire.com

WGS DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 3 Deadline in Securities Class Action - WGS

July 31 at 2:12 PM | newsfilecorp.comN

GENEDX HOLDINGS DEADLINE MONDAY AUGUST 3rd: Bragar Eagel & Squire, P.C. Urges GeneDx Holdings Corp. Investors to Contact the Firm Regarding Lead Plaintiff Deadline

July 31 at 2:04 PM | globenewswire.com

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

July 31 at 1:55 PM | newsfilecorp.comN

WGS DEADLINE: The Gross Law Firm Reminds GeneDx Holdings Corp. Investors of Upcoming Securities Class Action Deadline

July 31 at 10:01 AM | globenewswire.com

MONDAY DEADLINE: GeneDx Holdings Corp. (WGS) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

July 31 at 6:55 AM | globenewswire.com

GeneDx Holdings Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - WGS

July 31 at 4:08 AM | prnewswire.com

GeneDx Holdings Corp. Investor Alert: Contact SBS by August 3, 2026 for Opportunity to Lead Securities Fraud Lawsuit

July 31 at 3:14 AM | prnewswire.com

WGS 4-DAY DEADLINE ALERT: GeneDx Holdings Corp. (NASDAQ: WGS) Investors Urged to Contact Hagens ...

July 31 at 1:18 AM | enidnews.comE

WGS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

July 30 at 7:16 PM | newsfilecorp.comN

WGS 4-DAY DEADLINE ALERT: GeneDx Holdings Corp. (NASDAQ: WGS) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 3, 2026 Lead Plaintiff Deadline

July 30 at 5:21 PM | globenewswire.com

GeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp. - WGS

July 30 at 11:48 AM | globenewswire.com

MONDAY DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - WGS

July 30 at 10:20 AM | newsfilecorp.comN

Zacks Research Upgrades GeneDx (NASDAQ:WGS) to Hold

July 30 at 6:11 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

TOI, CDNA, WGS, and TDOC Company Descriptions

CareDx NASDAQ:CDNA

$43.71 +5.61 (+14.72%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$43.10 -0.61 (-1.38%)

As of 07/31/2026 07:41 PM Eastern

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.

Teladoc Health NYSE:TDOC

$6.71 +0.13 (+2.01%)

Closing price 07/31/2026 03:59 PM Eastern

Extended Trading

$6.71 0.00 (-0.03%)

As of 07/31/2026 07:56 PM Eastern

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

Oncology Institute NASDAQ:TOI

$4.86 -0.21 (-4.14%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$4.90 +0.04 (+0.91%)

As of 07/31/2026 07:44 PM Eastern

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

GeneDx NASDAQ:WGS

$65.11 -3.85 (-5.58%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$64.87 -0.24 (-0.37%)

As of 07/31/2026 07:34 PM Eastern

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TOI, CDNA, WGS, and TDOC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TOI, CDNA, WGS, and TDOC Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TOI, CDNA, WGS, and TDOC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

TOI, CDNA, WGS, and TDOC Company Descriptions

CareDx NASDAQ:CDNA

Teladoc Health NYSE:TDOC

Oncology Institute NASDAQ:TOI

GeneDx NASDAQ:WGS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TOI, CDNA, WGS, and TDOC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TOI, CDNA, WGS, and TDOC Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TOI, CDNA, WGS, and TDOC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

TOI, CDNA, WGS, and TDOC Company Descriptions

CareDx NASDAQ:CDNA

Teladoc Health NYSE:TDOC

Oncology Institute NASDAQ:TOI

GeneDx NASDAQ:WGS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools